HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-JUL-11 3SVV TITLE CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE- TITLE 2 PYRAZOLOPYRIMIDINE 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 251-533; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: BANTAM,CHICKENS; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS COVALENTLY BOUND LIGAND, CYSTEINE GATEKEEPER, SRC, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.L.GARSKE,U.PETERS,A.CORTESI,J.PEREZ,K.M.SHOKAT REVDAT 4 13-MAR-24 3SVV 1 COMPND SOURCE REVDAT 3 13-SEP-23 3SVV 1 REMARK SEQADV LINK REVDAT 2 26-OCT-11 3SVV 1 JRNL REVDAT 1 17-AUG-11 3SVV 0 JRNL AUTH A.L.GARSKE,U.PETERS,A.T.CORTESI,J.L.PEREZ,K.M.SHOKAT JRNL TITL CHEMICAL GENETIC STRATEGY FOR TARGETING PROTEIN KINASES JRNL TITL 2 BASED ON COVALENT COMPLEMENTARITY. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 15046 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21852571 JRNL DOI 10.1073/PNAS.1111239108 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_538 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 36099 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.520 REMARK 3 FREE R VALUE TEST SET COUNT : 1991 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.0827 - 4.7414 0.99 3588 207 0.1679 0.2071 REMARK 3 2 4.7414 - 3.7660 0.99 3544 211 0.1528 0.1982 REMARK 3 3 3.7660 - 3.2907 0.99 3579 211 0.1793 0.2033 REMARK 3 4 3.2907 - 2.9901 0.98 3497 198 0.1862 0.2107 REMARK 3 5 2.9901 - 2.7760 0.96 3474 217 0.1916 0.2217 REMARK 3 6 2.7760 - 2.6124 0.95 3421 209 0.1918 0.2649 REMARK 3 7 2.6124 - 2.4817 0.94 3371 177 0.1803 0.2019 REMARK 3 8 2.4817 - 2.3737 0.92 3334 197 0.1767 0.2458 REMARK 3 9 2.3737 - 2.2824 0.89 3229 177 0.1844 0.2311 REMARK 3 10 2.2824 - 2.2036 0.86 3071 187 0.1990 0.2414 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 21.09 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.67830 REMARK 3 B22 (A**2) : 8.58160 REMARK 3 B33 (A**2) : 17.92810 REMARK 3 B12 (A**2) : 1.19550 REMARK 3 B13 (A**2) : 1.16850 REMARK 3 B23 (A**2) : 4.77880 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4257 REMARK 3 ANGLE : 1.229 5775 REMARK 3 CHIRALITY : 0.076 618 REMARK 3 PLANARITY : 0.005 733 REMARK 3 DIHEDRAL : 17.620 1601 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -10.3373 32.4970 -12.2588 REMARK 3 T TENSOR REMARK 3 T11: -0.0809 T22: -0.1217 REMARK 3 T33: -0.0769 T12: 0.0035 REMARK 3 T13: 0.0339 T23: 0.0390 REMARK 3 L TENSOR REMARK 3 L11: 0.0111 L22: 0.0556 REMARK 3 L33: 0.0099 L12: 0.0081 REMARK 3 L13: 0.0024 L23: 0.0162 REMARK 3 S TENSOR REMARK 3 S11: -0.0291 S12: -0.0825 S13: 0.0839 REMARK 3 S21: -0.0235 S22: -0.0641 S23: -0.0277 REMARK 3 S31: -0.0023 S32: -0.0495 S33: -0.2396 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SVV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066716. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0088 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.2.4 REMARK 200 STARTING MODEL: PDB ENTRY 1YOJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES, 50MM NAOAC, 4-8% PEG 4000, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 CYS A 277 REMARK 465 LEU A 410 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 PHE A 424 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 GLY B 276 REMARK 465 CYS B 277 REMARK 465 PHE B 278 REMARK 465 GLY B 300 REMARK 465 ALA B 408 REMARK 465 ARG B 409 REMARK 465 LEU B 410 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 465 PHE B 424 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 275 CG CD OE1 NE2 REMARK 470 PHE A 278 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 LEU A 407 CG CD1 CD2 REMARK 470 ARG A 409 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 477 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 265 CG CD OE1 OE2 REMARK 470 ARG B 268 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 297 CG CD1 CD2 REMARK 470 LYS B 298 CG CD CE NZ REMARK 470 THR B 301 OG1 CG2 REMARK 470 MET B 302 CG SD CE REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 LYS B 316 CG CD CE NZ REMARK 470 GLU B 353 CG CD OE1 OE2 REMARK 470 LEU B 407 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 270 -60.06 -98.01 REMARK 500 ARG A 385 -13.13 89.32 REMARK 500 ASP A 386 40.47 -141.19 REMARK 500 LEU A 407 -173.27 179.58 REMARK 500 ARG B 385 -18.04 86.76 REMARK 500 ASP B 386 47.08 -143.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 INTERACTION BETWEEN THE LIGAND AND THE PROTEIN RESULTS IN THE REMARK 600 CHANGE OF BOND ORDER FROM DOUBLE TO SINGLE BOND BETWEEN THE REMARK 600 REACTING CARBON AND THE PENULTIMATE ONE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VSP A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VSP B 600 DBREF 3SVV A 251 533 UNP P00523 SRC_CHICK 251 533 DBREF 3SVV B 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 3SVV GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 3SVV HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 3SVV MET A 250 UNP P00523 EXPRESSION TAG SEQADV 3SVV CYS A 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 3SVV GLY B 248 UNP P00523 EXPRESSION TAG SEQADV 3SVV HIS B 249 UNP P00523 EXPRESSION TAG SEQADV 3SVV MET B 250 UNP P00523 EXPRESSION TAG SEQADV 3SVV CYS B 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL CYS SEQRES 8 A 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL CYS SEQRES 8 B 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET VSP A 600 26 HET VSP B 600 26 HETNAM VSP N-(3-{[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[3,4- HETNAM 2 VSP D]PYRIMIDIN-3-YL]METHYL}PHENYL)ETHANESULFONAMIDE FORMUL 3 VSP 2(C17 H22 N6 O2 S) FORMUL 5 HOH *234(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 SER A 303 LEU A 317 1 15 HELIX 3 3 SER A 345 GLY A 352 1 8 HELIX 4 4 MET A 354 LEU A 358 5 5 HELIX 5 5 ARG A 359 MET A 380 1 22 HELIX 6 6 ARG A 388 ALA A 390 5 3 HELIX 7 7 GLU A 396 LEU A 398 5 3 HELIX 8 8 PRO A 425 THR A 429 5 5 HELIX 9 9 ALA A 430 GLY A 437 1 8 HELIX 10 10 THR A 440 THR A 457 1 18 HELIX 11 11 VAL A 467 ARG A 477 1 11 HELIX 12 12 PRO A 488 TRP A 499 1 12 HELIX 13 13 ASP A 502 ARG A 506 5 5 HELIX 14 14 THR A 508 ASP A 518 1 11 HELIX 15 15 ASP A 518 THR A 523 1 6 HELIX 16 16 PRO B 263 GLU B 265 5 3 HELIX 17 17 SER B 303 LEU B 317 1 15 HELIX 18 18 SER B 345 GLY B 352 1 8 HELIX 19 19 GLU B 353 TYR B 357 5 5 HELIX 20 20 ARG B 359 MET B 380 1 22 HELIX 21 21 ARG B 388 ALA B 390 5 3 HELIX 22 22 GLU B 396 LEU B 398 5 3 HELIX 23 23 PRO B 425 THR B 429 5 5 HELIX 24 24 ALA B 430 GLY B 437 1 8 HELIX 25 25 THR B 440 THR B 457 1 18 HELIX 26 26 VAL B 467 ARG B 477 1 11 HELIX 27 27 PRO B 488 TRP B 499 1 12 HELIX 28 28 ASP B 502 ARG B 506 5 5 HELIX 29 29 THR B 508 ASP B 518 1 11 HELIX 30 30 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLU A 280 TRP A 286 -1 O THR A 285 N ARG A 268 SHEET 3 A 5 THR A 290 THR A 296 -1 O ILE A 294 N TRP A 282 SHEET 4 A 5 TYR A 335 GLU A 339 -1 O CYS A 338 N ALA A 293 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N ALA A 327 O VAL A 337 SHEET 1 B 2 ILE A 392 VAL A 394 0 SHEET 2 B 2 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 5 LEU B 267 GLY B 274 0 SHEET 2 C 5 GLU B 280 TRP B 286 -1 O VAL B 281 N LEU B 273 SHEET 3 C 5 THR B 290 THR B 296 -1 O ILE B 294 N TRP B 282 SHEET 4 C 5 TYR B 335 GLU B 339 -1 O CYS B 338 N ALA B 293 SHEET 5 C 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 D 2 ILE B 392 VAL B 394 0 SHEET 2 D 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 LINK SG CYS A 338 C18 VSP A 600 1555 1555 1.79 LINK SG CYS B 338 C18 VSP B 600 1555 1555 1.79 CISPEP 1 GLU A 332 PRO A 333 0 -11.69 CISPEP 2 GLU B 332 PRO B 333 0 -6.64 SITE 1 AC1 13 HOH A 56 HOH A 123 LEU A 273 ALA A 293 SITE 2 AC1 13 GLU A 310 MET A 314 VAL A 323 CYS A 338 SITE 3 AC1 13 GLU A 339 TYR A 340 MET A 341 LEU A 393 SITE 4 AC1 13 ASP A 404 SITE 1 AC2 16 HOH B 1 HOH B 151 HOH B 203 LEU B 273 SITE 2 AC2 16 ALA B 293 LYS B 295 GLU B 310 MET B 314 SITE 3 AC2 16 VAL B 323 LEU B 325 CYS B 338 GLU B 339 SITE 4 AC2 16 MET B 341 LEU B 393 ALA B 403 ASP B 404 CRYST1 42.300 63.315 74.230 78.93 87.70 87.92 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023641 -0.000860 -0.000798 0.00000 SCALE2 0.000000 0.015804 -0.003071 0.00000 SCALE3 0.000000 0.000000 0.013735 0.00000